Physician profile
Matthew Mackay
NPI 1790213783
$22,676.55
in general payments reported to CMS, 2019-2025
15 companies · $504 in 2025
The $504 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $20K · 2023: $1,720 · 2024: $328 · 2025: $504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,572 · Travel and Lodging: $980.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,571.79 |
| Travel and Lodging | $980.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $21,209.19 | 2022-2023 | |
| Stryker Corporation | $990.01 | 2022-2025 | Blueprint Patient Specific Instrumentation, Mako, T2 |
| Ferring Pharmaceuticals INC. | $125.16 | 2024-2025 | Euflexxa |
| Miach Orthopaedics, INC. | $109.09 | 2023 | |
| Titan Surgical Group, LLC | $48.12 | 2024 | |
| Skeletal Dynamics INC | $30.00 | 2024 | Ijs, Geminus, Implate |
| Radius Health, INC. | $24.22 | 2025 | Tymlos |
| Ani Pharmaceuticals, INC. | $22.54 | 2025 | Purified Cortrophin Gel |
| Sanofi-Aventis U.S. LLC | $20.69 | 2023 | |
| Vericel Corporation | $18.51 | 2025 | Maci |
| Vertex Pharmaceuticals Incorporated | $18.06 | 2025 | |
| Bioventus LLC | $17.98 | 2024 | Exogen Ultrasound Bone Healing System |
| Fidia Pharma USA INC. | $14.88 | 2025 | Triluron, Hymovis |
| Pacira Pharmaceuticals Incorporated | $14.15 | 2024 | Iovera, Zilretta |
| Encore Medical, Lp | $13.95 | 2023 | Djo Surgical |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Mackay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.